Clinical Trials in Boston

Showing 2741-2760 of 8,503 trials

Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells

NCT04626583

This study is a longitudinal assessment using a classic dose-escalation study design to assess the safety and maximal tolerated dose (MTD) of locally delivered allogeneic mesenchymal stromal cells (MSC) for promoting corneal repair. The study will be conducted at Illinois Eye and Ear Infirmary located at University of Illinois at Chicago. The study will use digital conjunctival and corneal photography and corneal Scheimpflug Imaging, densitometry, and pachymetry for assessment of safety and corneal wound healing.

Mesenchymal Stromal CellsCorneaSafety+1 more

University of Illinois at Chicago8 participantsStarted Mar 2021

Chicago, Illinois, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +1 more locations

COMPLETEDNA< 1 mile

Front-of-Package Nutrition Labels

NCT06516627

The goal of this study is to determine whether certain front-of-package food labeling systems improve the healthfulness of consumers' grocery selections. US adults who are their households' primary shoppers will complete a shopping task in a naturalistic online grocery store. They will be exposed to different front-of-package food labeling systems and asked to shop for groceries. The online store will record participants' selections. Participants will also be asked to complete survey measures.

NutritionFood SelectionFood Preferences+2 more

Harvard Pilgrim Health Care5,638 participantsStarted Oct 2024

Boston, Massachusetts, United States

Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells

Front-of-Package Nutrition Labels

Find Trials by Condition in Boston

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

A Mobile Tai Chi Platform for Fall Prevention in Older Adults - Phase II

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Study of ATH434 in Participants with Multiple System Atrophy

AAV Gene Therapy Study for Subjects with PKU

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Nitrous Oxide for the Treatment of Major Depressive Disorder

Honest, Open, Proud for Soldiers with Mental Illness